MOESM1 of A six-gene prognostic model predicts overall survival in bladder cancer patients

Figshare2019-09-05 更新2026-04-29 收录

数据链接：

https://figshare.com/articles/dataset/MOESM1_of_A_six-gene_prognostic_model_predicts_overall_survival_in_bladder_cancer_patients/9776699 数据链接链接失效反馈

官方服务：

资源简介：

Additional file 1: Table S1. Expression level of 167 driven genes.

创建时间：

2019-09-05

Tumor Stemness Score to Estimate Epithelial-to-Mesenchymal Transition (EMT) and Cancer Stem Cells (CSCs) Characterization and to Predict the Prognosis and Immunotherapy Response in Bladder Urothelial Carcinoma. Tumor Stemness Score to Estimate Epithelial-to-Mesenchymal Transition (EMT) and Cancer Stem Cells (CSCs) Characterization and to Predict the Prognosis and Immunotherapy Response in Bladder Urothelial Carcinoma

膀胱癌预后

治疗反应预测

Background: The relationships between cancer stem cells (CSCs), epithelial-to-mesenchymal transition (EMT), and the tumor microenvironment (TME) in bladder urothelial carcinoma (BLCA) remain unclear.

NIAID Data Ecosystem110

Table_1_Circulating Tumor DNA Analyses Predict Disease Recurrence in Non-Muscle-Invasive Bladder Cancer.xlsx

膀胱癌预后

肿瘤DNA检测

Circulating tumor DNA (ctDNA) can be a prognostic biomarker for non-muscle-invasive bladder cancer (NMIBC); however, targeted sequencing has not been performed to detect ctDNA in NMIBC. We applied tar

NIAID Data Ecosystem70

Table_1_A novel T-cell proliferation-associated regulator signature pre-operatively predicted the prognostic of bladder cancer.xlsx

膀胱癌预后

免疫微环境

BackgroundBladder cancer (BCa) is a remarkably malignant and heterogeneous neoplastic disease, and its prognosis prediction is still challenging. Even with the mounting researches on the mechanisms of

NIAID Data Ecosystem40

Additional file 6 of Identification of immune-related and autophagy-related genes for the prediction of survival in bladder cancer

膀胱癌预后

生物标志物

Additional file 6: Table S6. Risk score of each sample from the training cohort.

Figshare2022-08-01 更新70

DataSheet_1_N6-Methylandenosine-Related lncRNAs Predict Prognosis and Immunotherapy Response in Bladder Cancer.xlsx

膀胱癌预后

免疫治疗响应评估

Both lncRNAs and the N6-methyladenosine (m6A) modification are key regulators of tumorigenesis and innate immunity. However, little is known about the m6A modification of lncRNAs and their clinical an

NIAID Data Ecosystem60

MOESM1 of A six-gene prognostic model predicts overall survival in bladder cancer patients

资源简介：

相关数据集